SOLVD is a multicenter NIH clinical trial to evaluate the use of the enalapril in patients with left ventricular dysfunction (ejection fraction less than 35%) to determine if progression of left ventricular dysfunction, symptoms and mortality can be attenuated by the routine use of this angiotension converting enzyme inhibitor.
Showing the most recent 10 out of 360 publications